BioLargo Inc (OTCQB:BLGO) said Wednesday that its Canadian subsidiary BioLargo Water Inc has kicked off a pre-commercial demo of the company’s Advanced Oxidation System (AOS) to treat captured stormwater in Southern California. In a statement, the Westminster, California-based company said the goal in the pilot phase is to show the technical and economic practicality of deploying BioLargo’s AOS technology to treat stormwater and reuse it in the United States and Canada.
Mojave Jane Brands Inc (CSE:JANE) (OTC:HHPHF) posted fiscal third-quarter results late Tuesday that highlighted the company's Golden State development. During the quarter, the vertically-integrated cannabis company underwent a transition from focusing on cultivation to working in extraction, distribution and consumer brands. On July 16, Mojave acquired a 21% stake in 2083 Group, which owns the on-demand cannabis delivery service Speedweed.
Mineworx Technologies Ltd., (TSXV:MWX) (OTCQB:MWXRF) released the results of its Annual General Meeting held today, with all the resolutions proposed to shareholders – which were detailed in the Management Information Circular dated June 25 - duly passed.
Cannvas MedTech Inc (CSE:MTEC) (OTCMKTS:CANVF) said Wednesday that it has signed up for a share exchange deal with 1216165 BC Ltd, better known as True Focus International, to get the exclusive rights to market its suite of products, and at the same time announced plans to change the company's name to Eurolife Brands Inc.
RYAH Medtech Inc, a privately-owned artificial intelligence (AI), big data and IoT device company focused on plant-based medicine dosing and analytics, announced that REYAH Group has been granted a patent to utilize AI for the analysis of medical cannabis data. RYAH is currently processing 37 medical indications across medical databases and clinical trials.
Constantine Metal Resources (CVE:CEM) (OTCMKTS:CNSNF) is proceeding with underground exploration at its flagship Palmer project in Alaska, it announced Wednesday. The junior explorer has received all necessary approvals from the state’s regulators to advance work at the company’s 51%-owned zinc-copper-gold-silver project, where a recently completed preliminary economic assessment outlined a high-margin underground mining operation.
Bragg Gaming Group (CVE:BRAG) (OTCMKTS:BRGFF) is hailing a major achievement from its subsidiary ORYX Gaming. The group announced Wednesday that ORYX has added a record number of operators to its gaming platform during the first half of 2019. ORYX welcomed 21 new operators to its platform, bringing the total to over 65.
Alternus Energy Inc (OTC:ALTN) said Wednesday it has agreed to pay $11.76 million (€10.5 million) for Zonepark Rilland BV and its 11.75 megawatts Rilland solar power plant in the Netherlands. The renewable energy company said the price includes the assumption of a $8.1 million (€7.2 million) senior bank loan. In addition, the seller will be entitled to receive an additional cash payout of up to $560,000 (€500,000) based on net cash proceeds received by the park over and above a set annual power output of 10,865 megawatts per hour.
Genprex, Inc. (NASDAQ:GNPX) has initiated the first phase of branding for its lead drug candidate, Oncoprex immunogene therapy for non-small cell lung cancer, and has completed the creation and submission of non-proprietary drug name selections to the American Medical Association’s United States Adopted Names (USAN) Council.
Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF) is eyeing near term revenue from its cannabis oil gel capsules as it continues to work towards bringing the product to market, it told investors Wednesday. In a corporate update, the group said it would start manufacturing commercial batches of oil-filled gel capsules at its facility in Ontario and request Health Canada approval to begin full scale production and sale.
BioLargo Inc’s (OTCMKTS:BLGO) engineering subsidiary has added another US Air Force subcontract to its arsenal, the company announced on Wednesday. The agreement is the third this month for BioLargo Engineering, Science & Technologies (BLEST), and will see it provide air quality environmental engineering services to bases in Kansas and Illinois. The previous contracts cover facilities in Texas and Arizona.
The Flowr Corporation (CVE:FLWR) (OTC:FLWPF) has signed up for TruTrace Technologies Inc’s (CSE:TTT) (OTCQB:TTTSF) medical cannabis verification pilot program run in partnership with Canadian retailer Shoppers Drug Mart. The program uses TruTrace’s StrainSecure technology to collect data from cannabis plants and performs genomic verification tests on future batches to insure quality and consistency.
Fireweed Zinc Ltd (CVE:FWZ) has revealed that using state-of-the-art X-ray fluorescence (XRF) ore sorting technology could substantially improve the economics of its flagship Macmillan Pass zinc project in Yukon. The firm said it carried out an initial test at the Boundary zone, which lies 15km northwest of the Jason zinc-lead-silver deposit, and is a potential open pit mine.
American Manganese Inc (OTCMKTS:AMYZF) (CVE:AMY), the critical metals and battery recycling group, said it has been encouraged by rock sampling at its Lonnie rare earth element and niobium project in British Columbia. In a statement, the group said that of 11 sample results reported in the release (39 rock chip samples were gathered), seven averaged 0.42% niobium.
CB2 Insights (CSE:CBII) (OTCQB:CBIIF), a medical cannabis analytics company, is adding new talent to its board of directors in the form of retired Johnson & Johnson (NYSE:JNJ) executive Peter Cummins. Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles, overseeing research and development, external innovation, regulatory affairs and other areas over the course of his career.
Ascent Industries Corp (CSE:ASNT) (OTCMKTS:PGTMF) updated investors Wednesday on the Supreme Court of British Columbia hearing concerning proceedings under the Companies Creditors Arrangement Act. The company noted that it has been granted a stay extension order, which extends the relief granted under the previous order made on May 31, 2019 to September 27, 2019.
Vendetta Mining Corp (CVE:VTT) (OTCMKTS:VDTAF) said it has now raised over C$1.6 million, after closing an additional private placing, which brought in C$.1.03 million. In March this year, the group unveiled a C$1.5 million private placement to advance its Pegmont Lead Zinc project in Australia, but has now raised more than that.
Ximen Mining Corp. (CVE:XIM) (OTCQB:XXMMF) has closed the second tranche of its draw-down equity financing facility with Alumina Partners (Ontario) Ltd., an affiliate of New York-based private equity firm Alumina Partners LLC. In the second tranche, which closed on July 26, the company drew down $250,000 from Alumina in exchange for 446,428 units of Ximen consisting of a common share priced at $0.56 per share and an 18 month warrant exercisable at $.875 per share. The hold expiry date for the placement is November 27, 2019. The investment agreement with Alumina will provide the Ximen with up to C$8.0 million over a 24-month period to finance its exploration and on-going acquisition of gold assets in British Columbia.
Nano One Materials Corp. (CVE:NNO) (OTCMKTS:NNOMF) has announced a warrant incentive program designed to encourage the early exercise of up to 1,650,000 of its outstanding unlisted warrants currently exercisable at a price of C$1.25 per common share until September 8, 2019. The group said that under the program – which will commence August 8 at 9:00 am PDT and expire on August 23 at 5:00 pm PDT – it is offering an inducement to each warrant holder of one additional share purchase warrant for each warrant early exercised. Each new warrant will entitle the holder to purchase one additional common share for a period of 14 months from the date of issuance of such Incentive Warrant, at a price of C$1.60. The Incentive Warrants will be subject to a four month hold period from the date of issuance.
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that its chief executive officer, Armando Anido will present a company overview at the Canaccord Genuity 39th Annual Growth Conference. The presentation will take place on Wednesday August 7, 2019 at 5:00PM EDT at the InterContinental Hotel in Boston, Massachusetts. The group said Anido will also present at the SVB Leerink Spotlight Series Conference on Rare and Genetic Diseases on August 8, 2019 at 11:00AM EDT at the Boston Harbor Hotel.